Executive record

Christopher Kim, MD

Public governance roles and source-backed Claims for this individual.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:christopher-kim-mdVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims1 sources

Key Claims

Biography

Inventor and developer of Apitox and founder of Apimeds Korea. Licensed physician in New Jersey, New York and Korea with Pain Medicine Specialist certification. Over twenty years treating chronically disabled patients with autoimmune diseases including MS.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. 2026 to end not publishedExecutive title: Chief Medical Officer · Organization not publishedAPUS 10-K executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

1 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. APUS 10-K executive officers

    sec filing · Source published: May 4, 2026 · Retrieved: May 15, 2026

    Supports 6 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at Apimeds Pharmaceuticals US, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Medical Officer · Claim reviewed: May 15, 2026
    • Other Company Role: Christopher Kim, MD is also linked to Apimeds Korea as Director. · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026